Recombinant Human PHYH Protein，His

The study of PHYH (phytanoyl-CoA 2-hydroxylase) recombinant proteins has gained significant attention due to their crucial role in the metabolism of fatty acids, particularly in the degradation of phytanic acid, a branched-chain fatty acid derived from dietary sources. Mutations in the PHYH gene can lead to a rare genetic disorder known as Refsum disease, characterized by the accumulation of phytanic acid in tissues, resulting in various neurological and visual impairments. Research on recombinant PHYH proteins aims to enhance our understanding of the enzyme's structure, function, and catalytic mechanisms. By producing these proteins in a lab setting, scientists can investigate the enzyme's activity, explore its binding affinity to phytanic acid and related substrates, and identify potential therapeutic targets. Furthermore, recombinant PHYH proteins serve as valuable tools for studying enzyme regulation and understanding the broader implications of fatty acid metabolism in health and disease. Through the development of high-yield expression systems and purification techniques, current studies seek to elucidate the biochemical pathways involved in lipid metabolism and to assess the potential of gene therapy or enzyme replacement strategies for treating Refsum disease and related conditions. Overall, the exploration of PHYH recombinant proteins is a promising avenue for advancing genetic understanding, developing novel therapies, and improving the quality of life for individuals affected by metabolic disorders associated with fatty acid accumulation.